title: Distinct roles of the repeat-containing regions and effector domains of the Vibrio vulnificus multifunctional-autoprocessing repeats-in-toxin (MARTX) toxin.
abstract: Vibrio vulnificus is a seafood-borne pathogen that destroys the intestinal epithelium, leading to rapid bacterial dissemination and death. The most important virulence factor is the multifunctional-autoprocessing repeats-in-toxin (MARTX) toxin comprised of effector domains in the center region flanked by long repeat-containing regions which are well conserved among MARTX toxins and predicted to translocate effector domains. Here, we examined the role of the repeat-containing regions using a modified V. vulnificus MARTX (MARTX(Vv)) toxin generated by replacing all the internal effector domains with β-lactamase (Bla). Bla activity was detected in secretions from the bacterium and also in the cytosol of intoxicated epithelial cells. The modified MARTX(Vv) toxin without effector domains retained its necrotic activity but lost its cell-rounding activity. Further, deletion of the carboxyl-terminal repeat-containing region blocked toxin secretion from the bacterium. Deletion of the amino-terminal repeat-containing region had no effect on secretion but completely abolished translocation and necrosis. Neither secretion nor translocation was affected by enzymatically inactivating the cysteine protease domain of the toxin. These data demonstrate that the amino-terminal and carboxyl-terminal repeat-containing regions of the MARTXVv toxin are necessary and sufficient for the delivery of effector domains and epithelial cell lysis in vitro but that effector domains are required for other cytopathic functions. Furthermore, Ca(2+)-dependent secretion of the modified MARTX(Vv) toxin suggests that nonclassical RTX-like repeats found in the carboxyl-terminal repeat-containing region are functionally similar to classical RTX repeats found in other RTX proteins.
  
  
  OBJECTIVE
  Up to 95% of deaths from seafood-borne infections in the United States are due solely to one pathogen, V. vulnificus. Among its various virulence factors, the MARTX(Vv) toxin has been characterized as a critical exotoxin for successful pathogenesis of V. vulnificus in mouse infection models. Similarly to MARTX toxins of other pathogens, MARTX(Vv) toxin is comprised of repeat-containing regions, central effector domains, and an autoprocessing cysteine protease domain. Yet how each of these regions contributes to essential activities of the toxins has not been fully identified for any of MARTX toxins. Using modified MARTX(Vv) toxin fused with β-lactamase as a reporter enzyme, the portion(s) responsible for toxin secretion from bacteria, effector domain translocation into host cells, rapid host cell rounding, and necrotic host cell death was identified. The results are relevant for understanding how MARTX(Vv) toxin serves as both a necrotic pore-forming toxin and an effector delivery platform.
authors.affiliation: Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
authors.forename: Byoung Sik
authors.initials: BS
authors.lastname: Kim
authors.affiliation: Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
authors.forename: Hannah E
authors.initials: HE
authors.lastname: Gavin
authors.affiliation: Department of Microbiology-Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA k-satchell@northwestern.edu.
authors.forename: Karla J F
authors.initials: KJ
authors.lastname: Satchell
mesh_terms: D001427:Bacterial Toxins / Q000378:metabolism*; D004252:DNA Mutational Analysis; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D006367:HeLa Cells; D006801:Humans; D017434:Protein Structure, Tertiary; D021381:Protein Transport; D017384:Sequence Deletion; D041261:Vibrio vulnificus / Q000378:metabolism*; D037521:Virulence Factors / Q000378:metabolism*
chemical_list: D001427:Bacterial Toxins; D037521:Virulence Factors
references.citation: Annu Rev Microbiol. 2011;65:71-90
references.pmid: 21639783
references.citation: Infect Immun. 2008 Apr;76(4):1509-17
references.pmid: 18250174
references.citation: PLoS Pathog. 2012;8(12):e1003072
references.pmid: 23236283
references.citation: J Biol Chem. 2013 Jan 11;288(2):1397-408
references.pmid: 23184949
references.citation: J Infect Dis. 2013 May 1;207(9):1406-15
references.pmid: 23225896
references.citation: EMBO J. 2000 Oct 16;19(20):5315-23
references.pmid: 11032799
references.citation: Infect Immun. 2001 Sep;69(9):5943-8
references.pmid: 11500479
references.citation: Infect Immun. 2003 Oct;71(10):5461-71
references.pmid: 14500463
references.citation: Plasmid. 2004 May;51(3):246-55
references.pmid: 15109831
references.citation: J Bacteriol. 2004 Aug;186(16):5486-95
references.pmid: 15292151
references.citation: N Engl J Med. 1979 Jan 4;300(1):1-5
references.pmid: 758155
references.citation: J Bacteriol. 1988 Jun;170(6):2575-83
references.pmid: 2836362
references.citation: Infect Immun. 1990 Dec;58(12):4106-16
references.pmid: 2174833
references.citation: J Bacteriol. 1992 Aug;174(16):5237-43
references.pmid: 1644749
references.citation: EMBO J. 1993 Sep;12(9):3357-64
references.pmid: 8253063
references.citation: Science. 1998 Jan 2;279(5347):84-8
references.pmid: 9417030
references.citation: Infect Immun. 1999 Mar;67(3):1393-404
references.pmid: 10024587
references.citation: FEMS Microbiol Lett. 1999 May 15;174(2):207-14
references.pmid: 10339810
references.citation: J Microbiol. 2005 Feb;43 Spec No:118-31
references.pmid: 15765065
references.citation: Mol Microbiol. 2006 Jul;61(2):310-23
references.pmid: 16856938
references.citation: Cell Microbiol. 2007 May;9(5):1324-35
references.pmid: 17474905
references.citation: Pathog Dis. 2013 Feb;67(1):11-8
references.pmid: 23620115
references.citation: Vaccine. 2014 Jan 3;32(2):271-6
references.pmid: 24252692
references.citation: Epidemiol Infect. 2014 Apr;142(4):878-81
references.pmid: 23842472
references.citation: Infect Immun. 2014 May;82(5):2148-57
references.pmid: 24614656
references.citation: PLoS Pathog. 2007 Dec;3(12):e196
references.pmid: 18159943
references.citation: Infect Immun. 2008 Jun;76(6):2620-32
references.pmid: 18378637
references.citation: Microbes Infect. 2008 Nov-Dec;10(14-15):1504-13
references.pmid: 18849006
references.citation: J Biol Chem. 2009 Jan 16;284(3):1781-9
references.pmid: 19015266
references.citation: J Biol Chem. 2009 Sep 25;284(39):26557-68
references.pmid: 19620709
references.citation: Nat Chem Biol. 2009 Jul;5(7):469-78
references.pmid: 19465933
references.citation: J Infect Dis. 2010 Jan 1;201(1):97-105
references.pmid: 19919301
references.citation: J Mol Biol. 2010 Mar 26;397(2):534-49
references.pmid: 20096704
references.citation: J Immunol. 2010 May 1;184(9):5287-97
references.pmid: 20348425
references.citation: J Mol Biol. 2010 Jul 9;400(2):244-56
references.pmid: 20438736
references.citation: Appl Environ Microbiol. 2011 Jan;77(2):657-68
references.pmid: 21075892
references.citation: Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1645-50
references.pmid: 21220343
references.citation: Int J Infect Dis. 2011 Mar;15(3):e157-66
references.pmid: 21177133
references.citation: J Infect Dis. 2011 Jun 15;203(12):1866-74
references.pmid: 21422475
references.citation: Biochim Biophys Acta. 2014 Sep;1844(9):1500-10
references.pmid: 24865936
references.citation: Proteins. 2014 Oct;82(10):2643-56
references.pmid: 24935440
references.citation: Toxins (Basel). 2015 Jan;7(1):1-20
references.pmid: 25559101
references.citation: Mol Microbiol. 2015 Feb;95(4):590-604
references.pmid: 25427654
references.citation: EMBO J. 2007 May 16;26(10):2552-61
references.pmid: 17464284
references.citation: J Microbiol. 2007 Apr;45(2):146-52
references.pmid: 17483800
references.citation: Microbes Infect. 2000 Feb;2(2):177-88
references.pmid: 10742690
references.citation: Infect Immun. 2007 Jul;75(7):3282-9
references.pmid: 17438022
references.citation: Cell Microbiol. 2008 Apr;10(4):848-62
references.pmid: 18005241
references.citation: PLoS Pathog. 2012;8(3):e1002581
references.pmid: 22457618